Stockscreener 앱 받기
2.09
4.50%
0.09
전일 마감가:
$2.00
열려 있는:
$2.04
하루 거래량:
3.55M
Relative Volume:
1.21
시가총액:
$320.55M
수익:
-
순이익/손실:
$-56.85M
주가수익비율:
-1.3406
EPS:
-1.559
순현금흐름:
-
1주 성능:
-5.00%
1개월 성능:
+2.45%
6개월 성능:
+35.71%
1년 성능:
+3.47%
1일 변동 폭
$1.99
$2.12
1주일 범위
$1.95
$2.40
52주 변동 폭
$0.825
$3.03
Fractyl Health Inc Stock (GUTS) Company Profile
명칭
Fractyl Health Inc
전화
781-902-8800
주소
3 VAN DE GRAAFF DRIVE, BURLINGTON
GUTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
2.09 | 306.74M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-15 | 개시 | H.C. Wainwright | Buy |
| 2025-08-28 | 개시 | Ladenburg Thalmann | Buy |
| 2024-02-28 | 개시 | Evercore ISI | Outperform |
| 2024-02-27 | 개시 | BofA Securities | Buy |
| 2024-02-27 | 개시 | Morgan Stanley | Overweight |
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
What margin trends mean for Fractyl Health Inc. stockLow Beta Stocks & Make Confident Moves With Forecasting Models - ulpravda.ru
Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - The Globe and Mail
Fractyl Health, Inc. Announces Chief Financial Officer Changes - MarketScreener
Fractyl Health appoints Lara Smith Weber as new CFO By Investing.com - Investing.com Canada
Fractyl Health Appoints New Chief Financial Officer - TipRanks
Fractyl Health appoints Lara Smith Weber as new CFO - Investing.com
Why a metabolic disease company is bringing in a new finance chief - Stock Titan
Fractyl Health announces catalyst-rich clinical and funding outlook - MSN
Fractyl Health: Advancing Revita and Rejuva Pipelines Toward 2026 Clinical and Regulatory Catalysts Supports Buy Rating - TipRanks
Fractyl Health Announces Catalyst-Rich Clinical and Funding Outlook - TipRanks
Fractyl Health outlines strategic outlook for 2026 - TipRanks
Millions stopping GLP-1 drugs face what's next as firm tests new option - Stock Titan
Fractyl Health’s REVEAL-1 study shows positive six-month results for Revita in maintaining weight and glycemic control post-GLP-1 use - MSN
Analysts Keep Buy Ratings on Fractyl Health (GUTS) - Finviz
Analysts keep buy ratings on Fractyl Health (GUTS) - MSN
Fractyl Health’s REVEAL-1 Study Shows Positive Six-Month Results for Revita in Maintaining Weight and Glycemic Control Post-GLP-1 Use - Yahoo Finance
More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals
Stop Loss: Why Fractyl Health Inc stock remains undervaluedWeekly Volume Report & Trade Opportunity Analysis - moha.gov.vn
Aug EndMonth: Why retail investors favor Fractyl Health Inc stock2025 Investor Takeaways & Low Volatility Stock Suggestions - moha.gov.vn
Entry Recap: Why Fractyl Health Inc stock remains resilientJuly 2025 Snapshot & AI Powered Market Entry Ideas - moha.gov.vn
GUTS SEC FilingsFractyl Health 10-K, 10-Q, 8-K Forms - Stock Titan
Is Fractyl Health Inc. stock in correction or buying zoneWeekly Market Report & Daily Stock Trend Watchlist - Улправда
Aug Technicals: Why Fractyl Health Inc stock remains undervaluedJuly 2025 Recap & Fast Moving Market Watchlists - moha.gov.vn
Can Fractyl Health Inc. stock deliver surprise earnings beatWeekly Investment Summary & Smart Swing Trading Techniques - Bölüm Sonu Canavarı
Canaccord Genuity reiterates Buy rating on Fractyl Health stock By Investing.com - Investing.com South Africa
Why retail investors favor Fractyl Health Inc. stock2025 Sector Review & Fast Entry High Yield Tips - DonanımHaber
Canaccord Genuity reiterates Buy rating on Fractyl Health stock - Investing.com
Why Fractyl Health Inc. stock remains resilient2025 Historical Comparison & Technical Entry and Exit Alerts - DonanımHaber
Why Fractyl Health Inc. stock is trending among retail tradersSwing Trade & Smart Money Movement Tracker - Улправда
Fractyl Health (GUTS) officer awarded 845,226 stock options at $2.24 - Stock Titan
Market Overview: Will Fractyl Health Inc. stock deliver shareholder value2025 Stock Rankings & Daily Profit Focused Stock Screening - Улправда
Will Fractyl Health Inc. stock deliver shareholder valueJuly 2025 Catalysts & Trade Opportunity Analysis Reports - Улправда
With 58% institutional ownership, Fractyl Health, Inc. (NASDAQ:GUTS) is a favorite amongst the big guns - Yahoo Finance
Fractyl Health (GUTS) officer receives 743,913 stock options at $2.24 - Stock Titan
Fractyl Health (GUTS) CEO receives 2,486,302 stock options grant - Stock Titan
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Fractyl Health Calls Tranche A Warrants - TipRanks
Fractyl Health Announces Call of Tranche A Warrants - TradingView — Track All Markets
Fractyl Health calls Tranche A warrants for exercise or cancellation By Investing.com - Investing.com India
Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones - The Manila Times
Fractyl Health (NASDAQ: GUTS) sets Dec. 30 deadline on Tranche A warrants - Stock Titan
Fractyl Health calls Tranche A warrants for exercise or cancellation - Investing.com
Fractyl Health, Inc. Announces Call of Tranche A Common Stock Purchase Warrants for Cancellation and Cash Consideration - Quiver Quantitative
Fractyl Health Announces Call of Tranche A Warrants Tied to - GlobeNewswire
Trend Report: Why Fractyl Health Inc stock remains resilientWeekly Trade Summary & Long-Term Growth Stock Strategies - moha.gov.vn
Fractyl Health Inc (GUTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):